IngredientesMacadamia is a genus of four species of trees in the flowering plant family Proteaceae. They are indigenous to Australia—specifically, northeastern New South Wales and central and southeastern Queensland. The macadamias grown commercially are principally of two species: the smooth-shelled Macadamia integrifolia and the rough-shelled M. tetraphylla; the two tend to hybridize beyond distinction. Macadamia integrifolia and M. tetraphylla produce edible kernels, whereas M. ternifolia and M. jansenii produce small and inedible nuts that contain high levels of cyanogenic glycosides.
Macadamia integrifolia is a small to medium-sized tree native to Australian rainforests, with common names including macadamia, smooth-shelled macadamia, bush nut, Queensland nut, Bauple nut, and nut oak; the trees grow to 15 metres in height. Macadamia tetraphylla is a tree species in the family Proteaceae native to Australia, whose common names include macadamia nut, bauple nut, prickly macadamia, Queensland nut, rough-shelled bush nut, and rough-shelled Queensland nut.
German-Australian botanist Ferdinand von Mueller named the genus Macadamia after his friend John Macadam, a noted scientist and secretary of the Philosophical Institute of Australia. The trees, which had long been known and used by the native Australian aborigines, had been discovered by British colonists in Queensland; in 1857, Walter Hill, Director of the Botany in Brisbane, used a vise to crack open one of the nuts and planted the seed. Baron von Mueller, who had been traveling with Hill, described the tree that year and named it after Scotsman John MacAdam, a friend, physician, and secretary of the Philosophical Institute of Australia, who died before ever tasting the nut that bears his name.
Indigenous Australian names for the tree include gyndl, jindilli, and boombera. Depending on region, the macadamia nut is sometimes referred to as the Queensland nut, bush nut, Maroochi nut, Bauple nut, and Hawaii nut.
Macadamia trees are evergreen trees whose size varies depending on their species. M. ternifolia is one of the shorter species, reaching heights of 6 metres, whereas rough-shelled macadamias can reach double this height at 12 metres. The branches can spread out to 10 metres. The leaves of M. integrifolia are simple, oblong, glossy, with entire wavy margins and are approximately 20 centimetres long and 10 cm wide. The flowers are white or pink, followed by woody, edible rounded fruits 2–3.5 cm in diameter. The macadamia tree is usually propagated by grafting and does not begin to produce commercial quantities of nuts until it is 7 to 10 years old.
The introduction of macadamia seeds to Hawaii in 1882 marked the beginning of their cultivation outside Australia. William H. Purvis, a British settler, brought the seeds to the islands, recognizing the potential of the volcanic soils and subtropical climate. By the early 20th century, Hawaii had established itself as a major producer, pioneering large-scale cultivation and processing techniques. It was not until the 1960s that Australia took on the macadamia as a serious commercial crop. Ironically, even as the macadamia has spread worldwide in commercial agriculture, it is now listed as a vulnerable species in its native Australia due to habitat loss and degradation. The loss and impoverishment of its habitat has resulted from clearance of lowland rainforest for agriculture and urban development, invasive weeds, and poorly-designed fire management systems.
Macadamia is available commercially in a wide variety of forms. Whole raw or roasted kernels are the most widely consumed form. Kernels may be ground and processed to make macadamia nut oil. Macadamia oil is prized as a skin care product, containing approximately 22 percent of the omega-7 palmitoleic acid, which makes it a botanical alternative to mink oil. This relatively high content of palmitoleic acid, plus macadamia's high oxidative stability, make it a desirable ingredient in cosmetics, especially skincare. Their versatility extends beyond snacking—macadamias can be enjoyed raw, roasted, or as an ingredient in granolas, alternative dairy products, and even skincare formulations, thanks to their nutrient-dense oil.
The rising trend in the consumption of healthy, safe, and functional foods has motivated studies on cold-pressed specialty oils, including macadamia nut oil. Cold-pressed macadamia nut oil (CPMO) is given preference by consumers over solvent-extracted and refined oil because of its exceptional quality attributes and safety.
Australia's First Nations Peoples have lived there for approximately 65,000 years and ate nuts from various species of plants that we now call macadamias. Indigenous Australians were the first to eat, use, and trade macadamias. For thousands of years before European settlement, the Aborigines of eastern Australia feasted on the native nuts which grew in the rainforests of the wet slopes of the Great Dividing Range.
The nut was given various names—kindal-kindal and boombera—by Aboriginal groups such as the Budjilla that gathered in northern NSW and south-eastern Queensland to feast on it as well as to use its oil as a base for liniment and face and body paint. For Aboriginal communities in eastern Australia, the macadamia—known by various names including baupal (Gubi Gubi) and kindal kindal (Bundjalung)—has been a seasonal staple for thousands of years. Harvested in late summer to autumn, macadamias were traditionally cracked with stones and eaten raw, roasted in the embers of a fire, or ground into paste.
The nuts were gathered from the forest floor, stored in cool hollows, and feasted on communally when ripe. The macadamia was not only a source of energy and nutrition—rich in protein and good fats—but also a trade item between clans. Some oral histories speak of nuts being bartered inland or along the coast in exchange for ochre or fishing gear.
Traditionally, Indigenous Australians would roast, grind, and soak macadamias to reduce bitterness. The high oil content of these nuts was a coveted addition to the indigenous diet. However, they were difficult to harvest in great quantities, so they were probably not a major staple food. The fallen nuts were collected in dilly bags and taken to feasting grounds. Some coastal Aboriginal middens contain large quantities of bush nut shells along with sea shells, often 15–20 km from the nearest trees.
Yugambeh Elder Patricia O'Connor shares a story that macadamia nuts were often planted by Indigenous people travelling through country. This marked the way for others, as well as providing sustenance for future generations.
The German explorer Ludwig Leichhardt was the first recorded non-Aboriginal to come across macadamias in the bush and collect them. In 1843, Leichhardt was the first European to collect macadamia plant specimens. Based on seeds imported from Australia in the 1880s—the resulting trees intended as windbreaks for sugarcane—the Hawaiian macadamia industry took off in the 1920s, and by 1938, 1,000 hectares were under nut.
Macadamia nuts contain the largest percentage of both total fat and monounsaturated fat (MUFA) of all edible nuts: 75% of energy from fat, most of which is MUFA (82%), with very little polyunsaturated fat (PUFA) and 12–18% saturated fat (SFA). The MUFA makeup is distinctive in that it is 17–19% palmitoleic acid, with most of the remainder being oleic acid.
Gas chromatography/mass spectrophotometry has identified 20 fatty acids in macadamia, the most abundant of which are oleic acid (40 to 51%), palmitoleic acid (24 to 36%), and palmitic acid (8.4 to 13.1%). Total lipids content ranges from 70.9 to 79.7 g of oil per 100 g dry solids.
The main monounsaturated fatty acid is oleic acid (C18:1), with substantial levels of palmitoleic acid (C16:1) present in the macadamia nut. The main polyunsaturated fatty acids present are linoleic acid (C18:2) and linolenic acid (C18:3). All varieties of macadamia oil are rich in monounsaturated fatty acids, mainly including oleic acid (61.74–66.47%) and palmitoleic acid (13.22–17.63%).
The palmitoleic acid content of macadamia is especially noteworthy from a biochemical standpoint. Unlike any other commercial crop, macadamia nuts contain high levels of palmitoleic acid, which comprises in excess of 19% of the fatty acid composition of macadamia nut oil.
Nuts also contain other potentially cardioprotective constituents, including phytosterols, tocopherols, and squalene. Beta-sitosterol is the most abundant sterol in macadamia, ranging in concentration from 991.2 to 2071.7 microg/g oil. Campesterol and stigmasterol are also present in significant concentrations. The total oil content of macadamias is the highest of any nut, averaging 74.7% of mass.
The monounsaturated fatty acid-rich macadamia nut oil also contains a significant concentration of bioactive phytochemicals, including β-sitosterol, α-tocopherol, α-tocotrienols, ρ-hydroxybenzoic acid, and caffeic acid. Alpha-tocopherol is the most prevalent tocopherol in macadamia, as in most other nuts except walnuts.
The polyphenol, α-tocotrienol, and squalene content varies among macadamia cultivars; multiple linear regression analysis indicated that the polyphenols and squalene content positively correlated with antioxidant capacity.
Several studies have reported functional bioactive compounds in macadamia, such as polyphenols (e.g., catechin and epicatechin), phytosterols like β-sitosterol and campesterol, vitamin E, and squalene that can exhibit antioxidant and other beneficial effects.
In roasted macadamia nuts, the total available polyphenol content increased by 25.6% and the oxidative stability index of kernels increased by 21.6% compared with raw nuts. Among 15 cultivars studied, polyphenol contents ranged from 19.74 to 123.40 GAE mg/kg in macadamia oil, showing large differences among cultivars.
Macadamia nuts are a valuable source of nutrients—in particular, monounsaturated fatty acids. In addition, macadamia nuts contain other important dietary constituents, including proteins, dietary fiber, vitamins, minerals, and phytochemicals.
A 100-gram serving of macadamia nuts contains approximately 718 calories, 14 g carbohydrates, 9 g fiber, 8 g protein, 76 g total fat, 12 g saturated fat, 58.9 g monounsaturated fat, and 1.5 g polyunsaturated fat, with 0 mg cholesterol.
Tree nuts provide high levels of amino acids and non-sodium mineral nutrients, including L-arginine and magnesium, that decrease inflammation, blood pressure, and oxidative stress. Tree nuts are also a valuable source of calcium, iron, and zinc, which can be absorbed insufficiently during phases of high dietary demand such as infancy, childhood, adolescence, pregnancy, and breastfeeding.
Macadamia nuts are particularly notable for their manganese content. A single serving of macadamia nuts provides 58% of the daily recommended value (DV) for manganese, making them an "excellent source" of this essential mineral. Manganese plays a pivotal role in regulating blood sugar, forming collagen for healthy skin and connective tissue, supporting bone density, and functioning as a potent antioxidant to protect cells from oxidative damage. Macadamias are also an excellent source of thiamine (vitamin B1), delivering 30% DV of thiamine, which helps convert food into energy and supports nervous system function.
The health effects attributed to macadamia nuts are proposed to arise from several interacting mechanisms:
This is the most extensively investigated area for macadamia nuts in human studies, and it is where the strongest available clinical evidence exists.
Key clinical trials:
A randomized, crossover, controlled feeding study (5-week diet periods) compared a macadamia nut-rich diet [42.5 g (1.5 ounces)/8.79 MJ (2100 kcal)] against an average American diet (AAD) on the lipid/lipoprotein profile of mildly hypercholesterolemic subjects (n = 25; 15 female, 10 male). Serum concentrations of total cholesterol (TC) and LDL cholesterol (LDL-C) following the macadamia nut diet were significantly lower than the AAD. The serum non-HDL cholesterol concentration and the ratios of TC:HDL-C and LDL-C:HDL-C were also reduced following the macadamia nut diet compared with the AAD. There was no change in serum triglyceride concentration. The authors concluded that macadamia nuts can be included in a heart-healthy dietary pattern that reduces lipid/lipoprotein CVD risk factors.
A 2023 randomized controlled study (the MAC Study: Macadamia Nut Effects on Adiposity and Cardiovascular Risk Factors) was a 2×2 cross-over study in free-living adults consuming their habitual diet, with and without macadamia nuts as 15% of daily energy. Each diet was consumed for 8 weeks with a 2-week washout period. With mixed model regression analysis, no significant changes in mean weight, BMI, waist circumference, percent body fat, or glycaemic parameters were observed, and non-significant reductions in plasma total cholesterol of 2.1% (−4.3 mg/dl; 95% CI −14.8, 6.1) and LDL-C of 4% (−4.7 mg/dl; 95% CI −14.3, 4.8) were observed. Cholesterol-lowering effects were modified by adiposity: greater lipid lowering occurred in those with overweight versus obesity, and in those with less than the median percent body fat. Daily consumption of macadamia nuts does not lead to gains in weight or body fat under free-living conditions in overweight or obese adults; non-significant cholesterol lowering occurred without altering saturated fat intake.
Systematic review-level evidence:
Results from several systematic reviews and meta-analyses have demonstrated that nut consumption (including walnuts, macadamia nuts, almonds, cashews, pistachios, Brazil nuts, and peanuts or a mixture) decreases total and LDL-C, or triglycerides. In the United States, the Food and Drug Administration (FDA) has qualified health claims for macadamia nuts, walnuts, and nuts in relation to coronary heart disease.
FDA Qualified Health Claim:
After conducting a systematic review of the available scientific data, the U.S. Food and Drug Administration completed a review and now allows a qualified health claim for macadamia nuts. The claim reads: "Supportive but not conclusive research shows that eating 1.5 ounces per day of macadamia nuts, as part of a diet low in saturated fat and cholesterol and not resulting in increased intake of saturated fat or calories, may reduce the risk of coronary heart disease."
The agency acknowledges that while whole or chopped macadamia nuts contain no cholesterol, they do not meet the regulatory definition of low saturated fat or low fat. According to the regulations, products with saturated fat above 4 grams per reference amount customarily consumed or 50 grams cannot qualify for a health claim, but raw macadamia nuts have 6.03 grams of saturated fat per 50 grams. The "qualified" (i.e., not conclusive) nature of this claim accurately reflects the state of the evidence.
Evidence strength: Moderate. Multiple randomized controlled trials and systematic reviews support beneficial effects on LDL cholesterol and total cholesterol, particularly in persons with mild hypercholesterolemia. Effects appear more modest under free-living (ad libitum) conditions and in individuals with obesity. Three of four studies that reported macronutrient intakes were controlled feeding studies confounded by a purposeful reduction in SFA in the macadamia diets compared to the reference diet. The effects of macadamia nuts in free-living conditions without a reduction in SFA are unclear.
Macadamia nuts have been shown to improve circulating lipid profiles and are thus particularly useful in hypercholesterolemic subjects. Other beneficial effects of macadamia nuts are their ability to reduce inflammation and oxidative stress, as well as possibly contributing to weight loss.
In the 2023 MAC Study randomized trial, no significant changes in glycaemic parameters were observed in free-living adults consuming macadamia nuts as 15% of daily energy over 8 weeks.
Evidence is accumulating that the lipid-lowering effects of dietary interventions, including nuts, are lower in the setting of overweight/obesity or insulin resistance. In a pooled analysis of nut consumption in twenty-five intervention trials, the cholesterol-lowering effects of nuts were greatest in participants with a normal weight (BMI <25 kg/m²), and progressively lower, though still significant, in those with overweight and obesity.
Evidence strength: Preliminary. While macadamia nuts have a low carbohydrate content and low glycemic impact consistent with blood sugar stability, direct human clinical trial evidence specifically on glycemic outcomes from macadamia nut consumption is limited. The 2023 MAC RCT found no significant effect on glycemic parameters. Broader tree-nut meta-analyses suggest modest improvements in glycemic control, but macadamia-specific glycemic data remain sparse.
Evidence suggests that the health benefits of nuts occur without an increase in body weight, body mass index (BMI), body fat, or waist circumference, despite their high fat content.
In the 2023 MAC Study, daily consumption of macadamia nuts does not lead to gains in weight or body fat under free-living conditions in overweight or obese adults. In three studies that examined body weight, two reported a small but significant lowering with macadamia nuts, while no change was seen in the third.
Evidence strength: Moderate that macadamia consumption does not cause weight gain despite high energy density, consistent with broader tree-nut literature. Evidence that macadamia nuts actively promote weight loss is limited and inconsistent.
Beneficial effects of macadamia nuts include their ability to reduce inflammation and oxidative stress. One review of six studies found that macadamia nuts helped decrease the risk factors for cardiovascular disease by reducing cholesterol levels and helping with inflammation and oxidative stress (which causes damage to cells).
The antioxidant content of macadamia—including tocopherols, polyphenols (catechin, epicatechin), and squalene—provides a plausible biochemical basis for anti-inflammatory effects. Roasting further increases the total available polyphenol content of macadamia nuts by 25.6%. However, rigorous, macadamia-specific human clinical trials measuring inflammatory biomarkers such as CRP as primary outcomes are limited; most evidence in this area derives from broader nut studies or in vitro work.
Evidence strength: Preliminary. Mechanistic and in vitro data are promising; broader nut literature supports anti-inflammatory effects. Macadamia-specific human trial data on inflammatory markers as primary endpoints are limited.
The unsaturated fatty acids and polyphenols in nuts may also have benefits for gut health. As is the case with most nuts, the soluble fiber in macadamia nuts may act as a prebiotic, meaning that it helps feed beneficial gut bacteria.
Evidence strength: Highly preliminary. While the fiber content and polyphenol profile of macadamia nuts are biologically plausible as prebiotic agents, macadamia-specific human clinical trials on gut microbiome endpoints have not been identified in the peer-reviewed literature. This area is extrapolated from broader nut research.
Macadamia nuts are excellent sources of calcium, magnesium, and potassium. These minerals are important for maintaining bone health. Phosphorus, another mineral present in high levels in macadamia nuts, is instrumental in restoring vital minerals to bones and teeth.
Macadamia nuts are an excellent source of manganese: a single serving provides 58% of the daily recommended value for manganese. Manganese plays a pivotal role in supporting bone density.
Evidence strength: Indirect and nutritional. There are no published macadamia-specific clinical trials on bone mineral density outcomes. The bone health association is based on the well-established roles of constituent minerals (manganese, calcium, magnesium, phosphorus) in bone metabolism, not from direct interventional evidence with macadamia nuts as the test substance.
Macadamia nuts also contain compounds such as tocotrienols (a form of vitamin E) and squalene. Tocotrienols are thought to reduce damage to the skin that comes with aging. The squalene found in cosmetics increases the amount of moisture in the skin. Research has indicated that the monounsaturated fatty acids found in macadamia nuts may help minimize wrinkles caused by sun exposure, improve skin hydration, and play a role in skin healing.
Aboriginal Australians used macadamia oil as body paint and massaged the oil into the skin as a means of rejuvenation. Macadamia oil is prized as a skin care product and its relatively high content of palmitoleic acid, plus macadamia's high oxidative stability, makes it a desirable ingredient in cosmetics, especially skincare.
Evidence strength: Preliminary, predominantly in vitro and observational. The specific mechanisms—involving tocotrienols, palmitoleic acid, and squalene—are biochemically plausible, but rigorous randomized controlled trials in humans examining macadamia oil or nut consumption as an intervention for skin health outcomes have not been identified in the peer-reviewed literature.
The following dosages are those reported in cited clinical and regulatory sources; they are not recommendations:
Common commercially available forms include: raw whole kernels, dry-roasted kernels, macadamia nut oil (cold-pressed and refined), macadamia nut butter, macadamia nut flour, and macadamia-based alternative milks. Macadamia nut oil is also widely used in topical skincare preparations.
Macadamia nuts are generally well tolerated in humans and are classified as a food, not a regulated supplement. While whole or chopped macadamia nuts contain no cholesterol, they are energy-dense, containing approximately 718 kcal per 100 g, and represent a significant caloric contribution when consumed in large amounts.
Allergy: Nuts are one of the most common foods causing allergic reactions in children and adults; an allergic reaction to macadamia nut has been documented. A skin prick test demonstrated a type-I hypersensitivity reaction with macadamia nut, confirming that macadamia nut ingestion can cause immediate-type allergic reactions. As with other tree nuts, some people may be highly allergic to macadamia nuts.
One of the most clinically significant and well-documented safety facts about macadamia nuts is their well-established toxicity to dogs. This is specific to canines and does not apply to humans.
Macadamia nut toxicosis is a syndrome that occurs in dogs after ingesting macadamia nuts. It is characterized by vomiting, weakness, hyperthermia, and CNS depression. Dogs are the only species in which clinical signs have been reported.
The mechanism of toxicity is not known. Dogs have developed clinical signs after ingesting macadamia nuts at 2.4 g/kg. The ASPCA National Animal Poison Center managed 29 cases of ingestion of commercially available macadamia nuts in dogs over a 5-year period. Clinical signs included, from most to least common: weakness, depression, vomiting, ataxia, tremor, hyperthermia, abdominal pain, lameness, stiffness, recumbency, and pale mucous membranes. The onset of clinical signs was reported as less than 12 hours in 79% of cases. The duration of clinical signs for the majority of cases was less than 24 hours.
No specific treatment is typically required because clinical signs generally are mild and self-limiting; dogs with more severe clinical signs may benefit from administration of IV fluids, analgesics, or antipyretics. Some dogs may also develop pancreatitis (inflammation of the pancreas) due to the high oil content of these nuts.
Even as the macadamia has spread worldwide in commercial agriculture, it is now listed as a vulnerable species in its native Australia due to habitat loss and degradation. The loss and impoverishment of its habitat has resulted from clearance of lowland rainforest for agriculture and urban development, invasive weeds, and poorly-designed fire management systems.
No specific, clinically documented drug interactions for macadamia nuts have been identified in the peer-reviewed literature reviewed for this article. Given the high fat content of macadamia nuts, co-ingestion with fat-soluble medications could theoretically alter absorption kinetics, but this has not been studied specifically for macadamia. The high energy density of macadamia nuts is a meaningful consideration in caloric management contexts.
Condiciones de salud que macadamia puede ayudar a apoyar.
Macadamia nuts are a source of tocotrienols (a potent form of vitamin E), flavonoids, and phytosterols that support antioxidant defense. Short-term macadamia nut consumption has been documented to favorably modify oxidative stress markers. In vitro and animal studies have identified specific antioxidant peptides and mechanisms including Nrf2/HO-1 pathway activation.
Macadamia nuts promote satiety through their high content of MUFAs, fiber, and protein, which slow digestion and modulate hunger hormones. Clinical evidence from nut trials including macadamia shows improved satiety scores versus refined carbohydrate comparators. Their palmitoleic acid (omega-7) content is specifically linked to reduced appetite signaling.
Evidence indicates that macadamia nuts improve markers of arterial health, primarily through reducing LDL cholesterol and oxidative modification of lipoproteins. Clinical reviews report that macadamia nut consumption reduces inflammation and oxidative stress linked to arterial damage. The MUFA and flavonoid content are the proposed active constituents.
Tree nut meta-analyses including macadamia show modest blood pressure-lowering effects. A ScienceDirect review noted limited evidence suggesting nuts (including macadamia) have a protective effect on blood pressure and endothelial function. The MUFA and polyphenol content are the proposed mechanisms. Evidence specific to macadamia nuts for blood pressure is weaker than for cholesterol.
Clinical meta-analyses of tree nut interventions including macadamia nuts show modest improvements in glycemic control. A meta-analysis of 12 RCTs found tree nuts (including macadamias) at ~56 g/day significantly decreased HbA1c and fasting glucose in type 2 diabetes. Macadamia nuts' low glycemic index, high MUFA, and fiber content slow glucose absorption and blunt postprandial glucose spikes.
Multiple clinical trials demonstrate that macadamia nut consumption reduces total and LDL cholesterol in hypercholesterolemic individuals. A randomized crossover feeding study in mildly hypercholesterolemic subjects showed significant reductions in TC and LDL-C compared to a typical American diet. The effect appears driven by the high monounsaturated fatty acid (MUFA) content displacing saturated fat. A 2023 RCT in overweight/obese adults found non-significant but directionally consistent LDL-C reductions of ~4%.
Macadamia nuts contain flavonoids, palmitoleic acid, and tocotrienols with anti-inflammatory properties. A review of six studies found that macadamia nuts help reduce inflammation associated with cardiovascular disease. Short-term macadamia consumption has been shown to favorably modify inflammatory markers despite increased fat intake. Broader nut research including macadamias shows modest reductions in C-reactive protein.
Macadamia nuts contain tocotrienols and MUFAs that are associated with neuroprotection and reduced risk of cognitive decline. Epidemiological studies link elevated plasma tocotrienol levels to reduced odds of mild cognitive impairment and Alzheimer's disease. Oleic acid protects against neuronal oxidative stress in animal models. Human RCT evidence specifically for macadamia nuts and cognition is limited.
Macadamia nuts contain prebiotic fiber and polyphenols that support gut microbiome diversity. Systematic reviews of tree nut clinical trials (including macadamia) found evidence of beneficial gut microbiota modulation and short-chain fatty acid production. Macadamia oil cake (a by-product) was shown in animal studies to regulate intestinal microbiota composition.
Macadamia nuts contribute to healthy aging through their antioxidant (tocotrienols, flavonoids), anti-inflammatory (MUFA, palmitoleic acid), and cardiometabolic benefits. Tocotrienols in macadamia nuts are specifically associated with neuroprotection and cognitive health maintenance in aging populations. Their nutrient density supports multiple systems implicated in age-related decline.
Despite being calorie-dense, macadamia nut consumption is not associated with weight gain and may support healthy weight maintenance. The 2023 MAC Study (n=35, 8-week RCT) showed no gains in weight, BMI, or body fat despite macadamias comprising 15% of daily energy intake. A broader body of nut research links regular consumption to lower long-term weight gain risk.
Clinical and epidemiological evidence supports macadamia nut consumption for reducing cardiovascular disease risk. A review of six studies found macadamia nuts decreased CVD risk factors including cholesterol, inflammation, and oxidative stress. Research suggests regular intake may help prevent coronary artery disease. The primary mechanism is the MUFA-rich fatty acid profile favorably modifying lipid and lipoprotein concentrations.
MUFA-rich diets, of which macadamia nuts are a primary source, are associated with improved insulin sensitivity. Meta-analyses of tree nut RCTs including macadamia show reduced HbA1c and fasting glucose in diabetic populations. Palmitoleic acid (omega-7), found in unusually high concentrations in macadamia, may improve insulin receptor signaling.
Tree nut meta-analyses including macadamia nuts show favorable effects on multiple components of metabolic syndrome—including fasting glucose, triglycerides, and cholesterol. Macadamia nuts' MUFA content and low glycemic profile address insulin resistance, dyslipidemia, and abdominal adiposity simultaneously. A meta-analysis of 47 RCTs found tree nuts significantly reduced triglycerides and fasting glucose in metabolic syndrome patients.
Meta-analyses of tree nut RCTs including macadamia nuts show reductions in fasting triglycerides, particularly in individuals with hypertriglyceridemia. A meta-analysis of 47 RCTs found ~2 oz/day of tree nuts decreased triglycerides by 0.06 mmol/L over ~8 weeks in metabolic syndrome subjects. However, controlled feeding trials specific to macadamia nuts did not consistently show triglyceride-lowering effects.
Macadamia nut oil has a longstanding traditional use as a topical moisturizer for dry skin, attributed to its high palmitoleic acid and squalene content that mimic skin sebum. It helps repair the skin barrier and reduce trans-epidermal water loss. While mechanistically plausible, large controlled clinical trials specifically demonstrating efficacy for dry skin are limited.
Macadamia nut oil is traditionally applied to soothe eczema patches, reduce itchiness, and repair the skin barrier. Its linoleic acid and palmitoleic acid content support barrier repair in eczema-prone skin. No peer-reviewed RCT using macadamia oil as a standalone treatment for diagnosed eczema has been identified.
Macadamia nut oil is used topically to reduce signs of skin aging, including fine lines and wrinkles. Palmitoleic acid and squalene in the oil are proposed to prevent lipid peroxidation, boost keratinocyte regeneration, and support collagen integrity. Evidence is primarily mechanistic and traditional, with limited independent clinical trials.
Macadamia nut oil is traditionally used to improve skin elasticity and support collagen production via its palmitoleic acid content. Palmitoleic acid has demonstrated the ability to assist in collagen synthesis in vitro. The oil's fatty acids support the structural integrity of the dermal matrix. Rigorous human RCT evidence is lacking.
Macadamia nut oil has traditional use for wound healing and skin repair, supported by animal studies on palmitoleic acid. Palmitoleic acid accelerates wound healing by promoting cell regeneration and reducing inflammation. Human clinical trial evidence for macadamia oil in wound healing is limited.
Sistemas corporales que macadamia puede ayudar a apoyar.
Volver